Markus Linder
Impact in
-
- Cancer-related molecular mechanisms research
-
- Psoriasis: Treatment and Pathogenesis
- Immunotherapy and Immune Responses
Papers in
-
- RNA Research and Splicing 2
- Ubiquitin and proteasome pathways 1
- Oncology 4
- Cytokine Signaling Pathways and Interactions 2
- Co-authors
- Maria Sibilia (6 shared papers)Latifa Bakiri (4 shared papers)Erwin F. Wagner (4 shared papers)Kazuhiko Matsuoka (2 shared papers)Martin Holcmann (2 shared papers)Amanda Mikels‐Vigdal (1 shared paper)Christine Hartmann (1 shared paper)Fernando Lecanda (1 shared paper)
- Journals
- EMBO Molecular Medicine (2 papers)Biomedicines (1 paper)Cell Death and Differentiation (1 paper)Cell Research (1 paper)Lab Animal (1 paper)
- Partner nations
- AustriaSwitzerlandSpain
In The Last Decade
Markus Linder
10 papers receiving 320 citations
Peers
Comparison fields: 5 of 72
- Cancer Research 51
- Immunology 70
- Oncology 64
- Molecular Biology 167
- Cell Biology 36
Countries citing papers authored by Markus Linder
This map shows the geographic impact of Markus Linder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus Linder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus Linder more than expected).
Fields of papers citing papers by Markus Linder
This network shows the impact of papers produced by Markus Linder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus Linder. The network helps show where Markus Linder may publish in the future.
Co-authors
The 25 scholars most cited alongside Markus Linder, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 88 | |
| 2 | 2018 | 70 | |
| 3 | 2021 | 61 | |
| 4 | 2017 | 41 | |
| 5 | 2018 | 23 | |
| 6 | 2022 | 18 | |
| 7 | 1999 | 10 | |
| 8 | 2023 | 6 | |
| 9 | Simultaneous Ang-2/VEGF-A inhibition prevents subretinal fibrosis progression in preclinical mouse models of choroidal neovascularization (CNV) | 2021 | 3 |
| 10 | 2024 | 2 |
About Markus Linder
Markus Linder is a scholar working on Molecular Biology, Oncology, Immunology, Organic Chemistry and Cellular and Molecular Neuroscience, having authored 10 papers that have together received 322 indexed citations. Recurring topics across this work include Cytokine Signaling Pathways and Interactions (2 papers), RNA Research and Splicing (2 papers), Sarcoma Diagnosis and Treatment (1 paper), Click Chemistry and Applications (1 paper), Ubiquitin and proteasome pathways (1 paper), Invertebrate Immune Response Mechanisms (1 paper), Retinal Diseases and Treatments (1 paper) and Corneal Surgery and Treatments (1 paper). The work is most often cited by research in Cancer Research (51 citations), Immunology (70 citations), Oncology (64 citations), Molecular Biology (167 citations) and Cell Biology (36 citations). Markus Linder has collaborated with scholars based in Austria, Switzerland and Spain. Frequent co-authors include Maria Sibilia, Latifa Bakiri, Erwin F. Wagner, Kazuhiko Matsuoka, Martin Holcmann, Amanda Mikels‐Vigdal, Christine Hartmann, Fernando Lecanda, Ana Patiño‐García and Elisabeth Glitzner. Their work appears in journals such as EMBO Molecular Medicine, Biomedicines, Cell Death and Differentiation, Cell Research and Lab Animal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.